Sofinnova Investments, Inc. Otonomy, Inc. Transaction History

Sofinnova Investments, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$1.22 - $2.2 $1.53 Million - $2.75 Million	-1,251,256 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$2.49 - $6.23 $3.41 Million - $8.53 Million	-1,369,412 Reduced 52.25%	1,251,256 $3.19 Million
Q4 2020 Feb 16, 2021	BUY	$3.48 - $6.47 $1.77 Million - $3.29 Million	509,072 Added 24.11%	2,620,668 $17 Million
Q3 2020 Nov 13, 2020	BUY	$3.16 - $4.36 $1.45 Million - $2.01 Million	460,185 Added 27.87%	2,111,596 $8.55 Million
Q2 2020 Aug 13, 2020	BUY	$1.87 - $3.84 $253,912 - $521,402	135,782 Added 8.96%	1,651,411 $5.98 Million
Q4 2019 Feb 14, 2020	BUY	$2.13 - $3.83 $165,424 - $297,453	77,664 Added 5.4%	1,515,629 $5.8 Million
Q3 2019 Nov 14, 2019	BUY	$2.12 - $2.86 $212,841 - $287,135	100,397 Added 7.51%	1,437,965 $3.44 Million
Q2 2019 Aug 13, 2019	BUY	$2.35 - $3.09 $737,202 - $969,342	313,703 Added 30.64%	1,337,568 $3.68 Million
Q4 2018 Feb 14, 2019	BUY	$1.51 - $2.93 $54,491 - $105,734	36,087 Added 3.65%	1,023,865 $1.89 Million
Q3 2018 Nov 15, 2018	BUY	$2.6 - $3.95 $20,280 - $30,810	7,800 Added 0.8%	987,778 $2.72 Million
Q2 2018 Nov 15, 2018	BUY	$3.7 - $4.75 $3.26 Million - $4.18 Million	880,104 Added 881.21%	979,978 $3.77 Million
Q2 2018 Aug 14, 2018	BUY	$3.7 - $4.75 $4,625 - $5,937	1,250 Added 1.27%	99,874 $385,000
Q1 2018 May 15, 2018	BUY	$4.05 - $6.1 $399,427 - $601,606	98,624 New	98,624 $414,000

Ticker OTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,990,400
Description
Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.